International Clinical Trial: Efficacy of Sublobar Resection Combined with Neoadjuvant Targeted Therapy in Early-Stage Non-Small Cell Lung Cancer: A Clinical Trial

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132899) titled 'Efficacy of Sublobar Resection Combined with Neoadjuvant Targeted Therapy in Early-Stage Non-Small Cell Lung Cancer: A Clinical Trial' on Sept. 20.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Shanghai Pulmonary Hospital

Condition: Non-small cell lung cancer (NSCLC)

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-09-20

Target Sample Size: Experimental group:48;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=335934

Published by HT Digital Content Services with permission from Health Daily Dig...